FDA Drug recall D-0622-2018
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc
- FDA Drug
- Class II
- terminated
- Published 2018-04-18
On 2018-04-18 the FDA classified a Class II recall of Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc by Elroselabs, citing cGMP Deviations.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0622-2018 |
| Classification | Class II |
| Status | terminated |
| Initiated | 2018-03-28 |
| Published | 2018-04-18 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Elroselabs |
| Distribution | US |
Product
Molleave, 2 oz bottle, OTC, Manufactured for Elrose Labs, Inc.
Reason
cGMP Deviations
Identifiers
| code_info | All product within expiry |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0622-2018%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.